CD8A and neoplasm: Evidence generated from intratumoral injection with wild‐type NDV in mice indicates that most of the beneficial effects are immune‐mediated by effector CD8 T cells and a synergistic combination with anti‐CTLA‐4 mAb was observed against tumor lesions not directly injected with virus (Zamarin et al, 2014).